Michael C. Greiner Net Worth

The estimated Net Worth of Michael Greiner is at least $5.16 Million dollars as of 18 March 2024. Mr Greiner owns over 4,219 units of Avanos Medical Inc stock worth over $3,660,836 and over the last 10 years he sold AVNS stock worth over $194,707. In addition, he makes $1,306,212 as Sr. VP and CFO & Principal Accounting Officer at Avanos Medical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr Greiner AVNS stock SEC Form 4 insiders trading

Mr has made over 5 trades of the Avanos Medical Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 4,219 units of AVNS stock worth $99,189 on 18 March 2024.

The largest trade he's ever made was exercising 10,400 units of Avanos Medical Inc stock on 12 July 2019 worth over $244,504. On average, Mr trades about 1,110 units every 148 days since 2014. As of 18 March 2024 he still owns at least 155,714 units of Avanos Medical Inc stock.

You can see the complete history of Mr Greiner stock trades at the bottom of the page.

Mr. Michael C. Greiner biography

Michael C. Greiner is the Sr. VP, CFO & Principal Accounting Officer at Avanos Medical Inc.

What is the salary of Mr Greiner?

As the Sr. VP and CFO & Principal Accounting Officer of Avanos Medical Inc, the total compensation of Mr Greiner at Avanos Medical Inc is $1,306,212. There are 2 executives at Avanos Medical Inc getting paid more, with Joseph Woody having the highest compensation of $5,023,670.

How old is Mr Greiner?

Mr Greiner is 48, he's been the Sr. VP and CFO & Principal Accounting Officer of Avanos Medical Inc since . There are 18 older and 1 younger executives at Avanos Medical Inc. The oldest executive at Avanos Medical Inc is Julie Shimer, 67, who is the Independent Director.

What's Mr Greiner's mailing address?

Michael's mailing address filed with the SEC is 5405, Windward Parkway, Milton, Alpharetta, Fulton County, Georgia, 30004, United States.

Insiders trading at Avanos Medical Inc

Over the last 6 years, insiders at Avanos Medical Inc have traded over $152,960 worth of Avanos Medical Inc stock and bought 24,500 units worth $834,605 . The most active insiders traders include Heidi Fields, Julie Ann Shimer, and Patrick J Oleary. On average, Avanos Medical Inc executives and independent directors trade stock every 194 days with the average trade being worth of $129,470. The most recent stock trade was executed by Michael Greiner on 18 March 2024, trading 4,219 units of AVNS stock currently worth $99,189.

What does Avanos Medical Inc do?

avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter.headquartered in alpharetta, georgia, avanos is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.avanos develops, manufactures and markets its recognized brands in more than 90 countries.

Complete history of Mr Greiner stock trades at Angiodynamic Inc, Cimpress plc, and Avanos Medical Inc

Avanos Medical Inc executives and stock owners

Avanos Medical Inc executives and other stock owners filed with the SEC include:

• Joseph Woody,
  Chief Executive Officer, Director
• Joseph F. Woody,
  CEO & Director
• Michael C. Greiner,
  Sr. VP, CFO & Principal Accounting Officer
• David Ball,
  Senior Vice President - Global Supply Chain and Procurement
• Arjun Sarker,
  Senior Vice President - International
• David Edward Ball,
  Sr. VP of Global Supply Chain & Procurement
• Arjun Ranjan Sarker,
  Sr. VP of International
• William David Haydon,
  Sr. VP & GM of Pain Management
• Heidi Kunz,
  Independent Director
• Julie Shimer,
  Independent Director
• William Hawkins,
  Independent Director
• Gary Blackford,
  Chairman of the Board
• Maria Sainz,
  Independent Director
• Patrick O'Leary,
  Independent Director
• John Byrnes,
  Independent Director
• S. Ross Mansbach,
  Senior Vice President, Interim General Counsel, Corporate Secretary
• William Haydon,
  Senior Vice President, General Manager
• Michelle Scharfenberg,
  Senior Vice President, Chief Ethics and Compliance Officer
• Dave Crawford,
  Vice President - Treasurer and Investor Relation
• Michael Greiner,
  Chief Financial Officer, Senior Vice President
• Lee Burnes,
  Sr. VP of Global R&D, Clinical and Medical Affairs
• Scott Galovan,
  VP of Strategy & Corp. Devel.
• Mojirade James,
  Sr. VP & Gen. Counsel
• Warren J. MacHan,
  Sr. VP of Bus. Strategy
• Moji James,
  Sr. VP & Gen. Counsel
• Rhonda D. Gibby,
  Sr. VP & Chief HR Officer
• David Crawford,
  VP of FP&A and Investor Relations and Treasurer
• Renato Negro,
  VP, Controller & Chief Accounting Officer
• John W Wesley,
  SVP, General Counsel
• Sudhakar Varshney,
  SVP, Global Supply Chain
• Renato Negro,
  Vice President - Controller
• Heidi Fields,
  Director
• Steven E Voskuil,
  SVP, Chief Financial Officer
• Ronald W Dollens,
  Director
• Warren J Machan,
  See Remarks
• John Raymond Tushar,
  President, Global Franchises
• Mojirade James,
  SVP, General Counsel
• John Joseph Hurley,
  Principal Accounting Officer
• Kerr Holbrook,
  SVP, Chief Commercial Officer
• Lisa Egbuonu Davis,
  Director